Bluebird Bio Inc (BLUE)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

60 BINNEY STREET CAMBRIDGE, MA 02142

bluebird bio is pioneering gene therapy with purpose. From its Cambridge, Mass., headquarters, they're developing gene and cell therapies for severe genetic diseases and cancer, with the goal that people facing potentially fatal conditions with limited treatment options can live their lives fully. Beyond their labs, the company is working to positively disrupt the healthcare system to create access, transparency and education so that gene therapy can become available to all those who can benefit.

Data as of 2021-09-19 12:41:02 -0400
Market Cap1.238 Billion Shares Outstanding67.579 Million Avg 30-day Volume1.126 Million
P/E Ratio-1.47013 Dividend Yield EPS-12.61
Price/Sales24.64 Debt to Equity1.48 EBITDA-835.661 Million
Price to Book Value1.26 Forward PE Enterprise Value398.338 Million
Total Cash839.701 Million Current Debt247.765 Million Gross Profit29.848 Million
BETA0.60147 52-week High/Low59.32 / 17.14 Next Earnings Date2021-11-04 Price to Cash FLow (P/CF) -8.9245
Data provided by IEX Cloud

Are you looking for these stocks instead?

View SEC Filings from BLUE instead.

View recent insider trading info

Funds Holding BLUE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BLUE BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MAUS MARCELA V.

12,163 2021-09-07 2

GREGORY PHILIP D CHIEF SCIENTIFIC OFFICER

114,682 2021-08-02 10

COLE JASON CHIEF OPERATING AND

  • LEGAL OFFICER
112,453 2021-08-02 10

BAIRD WILLIAM D III CHIEF FINANCIAL OFFICER

102,698 2021-08-02 4

LESCHLY NICK PRESIDENT AND CEO

577,998 2021-08-02 12

OBENSHAIN ANDREW PRESIDENT OF SGD

339,597 2021-08-02 8

LYNCH DANIEL

19,312 2021-06-15 1

DIXON WENDY L

13,762 2021-06-15 1

VACHON MARK

11,766 2021-06-15 1

AGWUNOBI JOHN O

14,433 2021-06-15 1

SELLERS WILLIAM R.

11,721 2021-06-15 1

IBRAHIM RAMY

10,359 2021-06-15 3

TORRES DENICE

10,859 2021-06-15 1

KLIMA THOMAS J CHIEF COMMERCIAL OFFICER, SGD

75,000 2021-06-01 2

DAVIDSON DAVID CHIEF MEDICAL OFFICER

47,787 2021-04-05 8

BURNETT KATY PRINCIPAL ACCOUNTING OFFICER

4,097 2021-02-16 3

SMITH-FARRELL JOANNE COO, ONCOLOGY

20,609 2021-01-05 4

FINGER ALISON CECILY CHIEF COMMERCIAL OFFICER

25,103 2021-01-05 4

WENTWORTH KORY JAMES PRINCIPAL ACCOUNTING OFFICER

9,512 2020-08-03 0

MELTON DOUGLAS

6,324 2020-06-18 0

SCHENKEIN DAVID P

6,832 2020-06-18 0

WALSH JEFFREY T. CHIEF STRATEGY OFFICER

  • Officer
40,921 2019-08-20 0

HIGH SUSANNA GATTI CHIEF OPERATING OFFICER

  • Officer
13,735 2018-12-06 0

MANDELL JAMES

  • Director
1,000 2018-09-10 0

HEDLEY MARY LYNNE

  • Director
3,700 2018-06-20 0

MARAGANORE JOHN

  • Director
5,843 2017-09-14 0

SULLIVAN ERIC PRINCIPAL ACCOUNTING OFFICER

  • Officer
5,974 2017-08-03 0

GILLIS STEVEN

  • Director
109,308 2015-07-28 0

FINER MITCHELL H. CHIEF SCIENTIFIC OFFICER

  • Officer
0 2015-06-01 0

TEPPER ROBERT I

  • Director
  • 10% Owner
89,017 2015-02-03 0

THIRD ROCK VENTURES LP

THIRD ROCK VENTURES GP, L.P.

TRV GP, LLC

  • 10% Owner
No longer subject to file 2015-02-03 0

DETORE JAMES M. CHIEF FINANCIAL OFFICER

  • Officer
0 2014-12-01 0

BAIN LINDA VP, FIN. & BUSINESS OPERATIONS

  • Officer
0 2014-02-26 0

TVM V LIFE SCIENCE VENTURES GMBH & CO KG

TVM CAPITAL GMBH

POLACK AXEL

SCHUHSLER HELMUT

GOLL ALEXANDRA

BIRNER HUBERT

FISCHER STEFAN

  • 10% Owner
2,254,357 2013-06-24 0

ARCH VENTURE FUND VII LP

ARCH VENTURE PARTNERS VII, L.P.

ARCH VENTURE PARTNERS VII, LLC

BYBEE CLINTON

CRANDELL KEITH

NELSEN ROBERT

  • 10% Owner
No longer subject to file 2013-06-24 0

MULDER GEERT-JAN

  • Director
No longer subject to file 2013-06-24 0

POLACK AXEL

  • Director
2,254,357 2013-06-24 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

MAUS MARCELA V.

2021-09-09 17:08:55 -0400 2021-09-07 A 7,500 a 7,500 direct

MAUS MARCELA V.

2021-09-09 17:08:55 -0400 2021-09-07 A 4,663 a 4,663 direct 2.2931 2.4609 2.4609 6 -1.7897 3

GREGORY PHILIP D CHIEF SCIENTIFIC OFFICER

2021-08-04 16:53:26 -0400 2021-08-02 A 33,927 a 80,756 direct -3.247 -27.213 -29.1844 0.0 1 -32.8952 11

COLE JASON CHIEF OPERATING AND LEGAL OFFICER

2021-08-04 16:52:47 -0400 2021-08-02 A 32,266 a 80,188 direct -3.247 -27.213 -29.1844 0.0 1 -32.8952 11

LESCHLY NICK PRESIDENT AND CEO

2021-08-04 16:53:05 -0400 2021-08-02 A 51,303 a 409,299 direct -3.247 -27.213 -29.1844 0.0 1 -32.8952 11

BAIRD WILLIAM D III CHIEF FINANCIAL OFFICER

2021-08-04 16:53:20 -0400 2021-08-02 A 33,585 a 69,114 direct -3.247 -27.213 -29.1844 0.0 1 -32.8952 11

OBENSHAIN ANDREW PRESIDENT OF SGD

2021-08-04 16:52:47 -0400 2021-08-02 A 200,000 a 200,000 direct

LESCHLY NICK PRESIDENT AND CEO

2021-08-04 16:53:05 -0400 2021-08-02 A 51,304 a 357,996 direct -3.247 -27.213 -29.1844 0.0 1 -32.8952 11

GREGORY PHILIP D CHIEF SCIENTIFIC OFFICER

2021-08-04 16:53:26 -0400 2021-08-02 A 33,926 a 114,682 direct -3.247 -27.213 -29.1844 0.0 1 -32.8952 11

COLE JASON CHIEF OPERATING AND LEGAL OFFICER

2021-08-04 16:52:47 -0400 2021-08-02 A 32,265 a 112,453 direct -3.247 -27.213 -29.1844 0.0 1 -32.8952 11

OBENSHAIN ANDREW PRESIDENT OF SGD

2021-08-04 16:52:47 -0400 2021-08-02 A 100,000 a 139,597 direct -3.247 -27.213 -29.1844 0.0 1 -32.8952 11

BAIRD WILLIAM D III CHIEF FINANCIAL OFFICER

2021-08-04 16:53:20 -0400 2021-08-02 A 33,584 a 102,698 direct -3.247 -27.213 -29.1844 0.0 1 -32.8952 11

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
BLUEBIRD BIO INC BLUE 2021-09-24 18:45:03 UTC -0.1866 0.2566 2300000
BLUEBIRD BIO INC BLUE 2021-09-24 18:15:03 UTC -0.1866 0.2566 2300000
BLUEBIRD BIO INC BLUE 2021-09-24 17:45:03 UTC -0.1866 0.2566 2300000
BLUEBIRD BIO INC BLUE 2021-09-24 17:15:03 UTC -0.1866 0.2566 2300000
BLUEBIRD BIO INC BLUE 2021-09-24 16:45:03 UTC -0.1859 0.2559 2300000
BLUEBIRD BIO INC BLUE 2021-09-24 16:15:03 UTC -0.1859 0.2559 2300000
BLUEBIRD BIO INC BLUE 2021-09-24 15:45:03 UTC -0.1859 0.2559 2300000
BLUEBIRD BIO INC BLUE 2021-09-24 15:15:04 UTC -0.1859 0.2559 2300000
BLUEBIRD BIO INC BLUE 2021-09-24 14:45:02 UTC -0.2632 0.3332 2300000
BLUEBIRD BIO INC BLUE 2021-09-24 14:15:02 UTC -0.2632 0.3332 2300000
BLUEBIRD BIO INC BLUE 2021-09-24 13:45:02 UTC -0.2632 0.3332 2300000
BLUEBIRD BIO INC BLUE 2021-09-24 13:15:03 UTC -0.2632 0.3332 2300000
BLUEBIRD BIO INC BLUE 2021-09-24 12:45:03 UTC -0.2632 0.3332 2300000
BLUEBIRD BIO INC BLUE 2021-09-23 22:15:03 UTC -0.2632 0.3332 2200000
BLUEBIRD BIO INC BLUE 2021-09-23 21:45:03 UTC -0.2653 0.3353 2200000
BLUEBIRD BIO INC BLUE 2021-09-23 21:15:03 UTC -0.2653 0.3353 2200000
BLUEBIRD BIO INC BLUE 2021-09-23 20:45:03 UTC -0.2662 0.3362 2200000
BLUEBIRD BIO INC BLUE 2021-09-23 20:15:03 UTC -0.2662 0.3362 2200000
BLUEBIRD BIO INC BLUE 2021-09-23 19:45:03 UTC -0.2662 0.3362 2200000
BLUEBIRD BIO INC BLUE 2021-09-23 19:15:03 UTC -0.2662 0.3362 2200000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
American Century Quantitative Equity Funds, Inc.- AC Alternatives Equity Market Neutral Fund BLUE -1060.0 shares, $-93015.0 2019-12-31 N-PORT
American Century Quantitative Equity Funds, Inc.- Core Equity Plus Fund BLUE -1237.0 shares, $-113581.34 2019-09-30 N-PORT
AGF Investments Trust- AGFIQ U.S. Market Neutral Momentum Fund BLUE -552.0 shares, $-23885.04 2020-12-31 N-PORT
American Century Quantitative Equity Funds, Inc.- NT Core Equity Plus Fund BLUE -3131.0 shares, $-287488.42 2019-09-30 N-PORT
FundVantage Trust- Gotham Enhanced Index Plus Fund BLUE -181.0 shares, $-8318.76 2020-03-31 N-PORT
FundVantage Trust- Gotham Defensive Long Fund BLUE -213.0 shares, $-9789.48 2020-03-31 N-PORT
AQR Funds- AQR Large Cap Relaxed Constraint Equity Fund BLUE -1199.0 shares, $-110092.18 2019-09-30 N-PORT
FundVantage Trust- Gotham Master Neutral Fund BLUE -3.0 shares, $-161.85 2020-09-30 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund BLUE -259.0 shares, $-11903.64 2020-03-31 N-PORT
VANGUARD TRUSTEES' EQUITY FUND- VANGUARD ALTERNATIVE STRATEGIES FUND BLUE -2509.0 shares, $-75270.0 2021-04-30 N-PORT
TIFF INVESTMENT PROGRAM- TIFF Multi-Asset Fund BLUE -8766.0 shares, $-280336.68 2021-06-30 N-PORT
AdvisorShares Trust- AdvisorShares Dorsey Wright Short ETF BLUE -8785.0 shares, $-280944.3 2021-06-30 N-PORT
FundVantage Trust- Gotham Hedged Plus Fund BLUE -748.0 shares, $-23921.04 2021-06-30 N-PORT
AQR Funds- AQR Alternative Risk Premia Fund BLUE -21642.0 shares, $-692111.16 2021-06-30 N-PORT
AQR Funds- AQR Multi-Asset Fund BLUE -2403.0 shares, $-76847.94 2021-06-30 N-PORT

Elevate your investments